Gene Query: ZC3H18

Dataset Description Geneva Score
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 85.38
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 31.2
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 27.5
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 26.61
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 20.1
Effect of FGF13 depletion on the H460 cell line 17.92
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 17.47
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 17.46
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 17.46
The role of FAM46C in myeloma cells [sequencing] 15.18
The role of FAM46C in myeloma cells 15.18
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 15.09
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 14.57
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 14.25
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 13.44
EWSR1 influences alternative splicing through direct and indirect mechanisms 13.14
CD73 knockdown effect in pancreatic cancer cell lines 13.03
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 12.88
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 12.88
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 12.67
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 12.57
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 12.38
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 11.95
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 11.95
miR941 overexpression experiment 11.95
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 11.92
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 11.6
MOF acetyl transferase regulates transcription and respiration in mitochondria 11.09
Studying the selectivity of a small molecule Synucleozid on transcriptome 10.97
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 10.88
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 10.87
RNA-seq in transgenic cells 10.61
Transcriptomic analysis of LSD1 10.55
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 10.5
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 10.45
Genome wide expression change by RNF168 knocking down in NEC cells 10.28
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 10.23
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 10.22
Identification of Nrf2 regulated genes by RNA sequencing 10.19
Nrf2 regulated genes in A549 cells 10.19
Effect of disulfiram treatment on pediatric high grade glioma 10.16
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 10.16
Disruption of the exocyst induces podocyte loss and dysfunction 10.15
FBXW7 modulates stress response by post-translational modification of HSF1 10.11
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 10.11
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 10.0
The evolution of N6-methyladenosine in primates 9.96
DART-seq: an antibody-free method for global m6A detection 9.94
TCF7L1 knockdown in pancreatic cancer 9.91
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 9.82
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 9.72
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 9.68
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 9.68
Genome wide expression change by RNF168 knocking down in MCF-7 cells 9.56
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 9.45
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 9.44
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 9.28
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 9.27
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 9.27
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 9.24
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 9.07
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 9.01
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 8.98
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 8.94
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 8.94
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 8.94
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 8.82
NKX2.2 8.74
RNA-Seq analysis of NKX2.2 knockdown in human pancreatic islets 8.74
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 8.74
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 8.7
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 8.68
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 8.63
ETV7 and interferon response 8.59
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 8.59
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 8.58
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 8.58
Tpl-2 and MEK small molecule inhibitors 8.54
Tpl-2 small molecule project 8.54
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 8.53
METTL3 promotes translation in human cancer cells 8.53
Intrahepatic MAIT cell gene expression revealed by RNA-seq 8.35
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 8.33
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 8.32
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 8.31
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 8.22
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 8.2
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 8.16
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 8.16
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 8.14
High-throughput sequencing of pluripotent cells 8.13
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 8.03
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 7.91
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 7.86
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 7.8
RNA splicing alteration on glioblastoma and normal neural stem cells 7.79
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 7.75
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 7.63
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 7.62
Global gene expression profile of dasatinib-resistant RCH-ACV cells 7.53
RNA sequencing of mechanically strained NHEKs and control NHEKs 7.47
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 7.46
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 7.45
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 7.41
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 7.38
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 7.34
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 7.34
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 7.23
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 7.23
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 7.22
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 7.21
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 7.21
Expression and functions of long noncoding RNAs during human T helper cell differentiation 7.2
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 7.19
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 7.18
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 7.15
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 7.11
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 7.1
Regulation of poly(A) tail and translation during the somatic cell cycle 7.09
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 7.04
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 7.02
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 7.0
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 7.0
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 6.99
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 6.99
Accurate annotation of human protein-coding small open reading frames 6.94
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 6.93
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 6.93
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 6.9
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 6.89
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 6.88
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 6.85
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 6.84
An integrative analysis of non-coding regulatory DNA variations associated with autism 6.8
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 6.8
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 6.79
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 6.71
Transcriptomic analysis of ERR alpha orphan nuclear receptor 6.69
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 6.67
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 6.67
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 6.66
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 6.63
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 6.62
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 6.59
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 6.59
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 6.56
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 6.54
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 6.5
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 6.47
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 6.46
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 6.46
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 6.43
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 6.42
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 6.42
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 6.35
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 6.32
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 6.31
RNA polymerase in pre-B-ALL cell lines 6.3
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 6.27
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 6.25
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 6.25
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 6.23
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 6.21
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 6.13
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 6.1
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 6.1
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 6.06
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 6.03
The interplay between SOX4 and SMAD3 in the context of breast cancer 6.02
R430: A potent inbibitor of DNA and RNA viruses 6.01
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 5.92
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 5.91
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 5.87
A549 cells and MSR-A549 cells 5.85
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 5.85
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 5.84
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 5.84
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 5.72
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 5.67
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 5.64
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 5.64
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 5.61
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 5.57
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 5.57
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 5.52
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 5.51
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 5.5
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 5.49
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 5.49
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 5.49
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 5.48
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 5.48
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 5.47
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 5.46
RNA transcriptome analysis during HSV-1 infection 5.43
RNA-sequencing in irradiated and normal A549 cells. 5.41
Mechanistic Model-Guided Study of Embryonic Morphogenesis 5.4
Landscape and variation of RNA secondary structure across the human transcriptome 5.37
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 5.37
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 5.35
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 5.31
ARS2 is a general suppressor of pervasive transcription [RNAseq] 5.25
RNA-seq analysis of BAP1-depleted uveal melanoma cells 5.24
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.23
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.23
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 5.23
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 5.21
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 5.17
Transcriptome analysis of SKI knock-out in HL60 cells 5.17
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 5.17
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 5.17
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 5.14
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 5.14
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 5.12
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 5.12
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 5.06
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 5.04
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 5.03
Conservative alteration of chromosomal expression pattern across human solid tumor types 5.03
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 5.0
Solid phase chemistry to covalently and reversibly capture thiolated RNA 4.99
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 4.97
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 4.97
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 4.97
The effect of Abl kinases on non-small cell carcinoma global transcriptome 4.97
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 4.96
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 4.92
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 4.92
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 4.86
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 4.86
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 4.85
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 4.85
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 4.82
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 4.78
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 4.76
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 4.76
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 4.76
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 4.72
IMP3 regulated gene expression in breast cancer cells 4.7
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 4.69
RNA-seq analysis of differentiating human erythroblasts 4.65
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 4.64
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.57
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 4.57
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 4.56
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 4.55
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 4.53
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 4.53
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 4.53
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 4.52
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 4.49
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 4.47
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 4.45
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 4.45
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 4.43
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 4.41
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 4.35
Capturing the Interactome of Newly Transcribed RNA (RICK) 4.34
Capturing the Interactome of Newly Transcribed RNA 4.34
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 4.33
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 4.31
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 4.31
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 4.31
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 4.19
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 4.12
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 4.11
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 4.11
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 4.1
Gene expression profiling of leukemia cells following asparagine depletion 4.09
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 4.0
Selective expression of long non-coding RNAs in a breast cancer cell progression model 3.99
O-glcnAc reprograms cellular energetics 3.97
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 3.91
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 3.9
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 3.89
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 3.85
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 3.85
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 3.85
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 3.81
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 3.81
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 3.79
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 3.79
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 3.78
RNAseq Study in CC-671 Treated Cal-51 Cells 3.78
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 3.69
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 3.69
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 3.69
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 3.68
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 3.66
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 3.66
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 3.61
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 3.61
Downregulation of LATS kinases alters p53 to promote cell migration 3.59
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 3.58
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 3.55
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 3.55
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 3.54
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 3.53
Energy Metabolism during Anchorage-Independence 3.48
3.47
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 3.46
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 3.46
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 3.4
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 3.4
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 3.39
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 3.39
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 3.38
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 3.38
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 3.33
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 3.3
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 3.29
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 3.29
Effect of drugs on transcriptomic profiles 3.23
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 3.21
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 3.18
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 3.15
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 3.12
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 3.07
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 3.07
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 3.04
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 2.94
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 2.92
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 2.9
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 2.89
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 2.88
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 2.81
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 2.78
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 2.7
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 2.7
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 2.7
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 2.69
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 2.69
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 2.67
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 2.67
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 2.67
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 2.67
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 2.64
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 2.63
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 2.63
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 2.57
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 2.57
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 2.53
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 2.53
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 2.51
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 2.5
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 2.5
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 2.46
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.45
RNA-Seq in neutrophils from Antiphospholipid Syndrome 2.42
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 2.41
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 2.41
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 2.39
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 2.34
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 2.32
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 2.29
Mutational landscape of splicing genes and functional consequences across 33 cancer types 2.24
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.23
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.22
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 2.22
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 2.19
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 2.18
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 2.13
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 2.13
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.09
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 2.08
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 2.08
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 2.06
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 2.06
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 2.06
SNHG5 siRNA knock down in HCT116 cells 2.03
ChIP-seq and RNA-seq from human lymphoma cell lines 2.03
RNA-seq data from human lymphoma cell lines 2.03
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 2.03
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 2.03
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.99
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 1.96
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.95
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 1.93
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 1.93
X-Ray induced DNA-Hydroxymethylation changes 1.91
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 1.85
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 1.85
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.83
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.82
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 1.77
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.75
HEK293 Heat-shock experiment 1.72
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 1.66
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 1.65
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 1.63
HEK293 TFAM Knockout Expression Study 1.62
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.6
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.58
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 1.58
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 1.57
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 1.57
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.54
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.54
Tracing Enhancer Networks using Epigenetic Traits (TENET) 1.52
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 1.46
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 1.37
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 1.27
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 1.27
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.26
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.26
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 1.24
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.22
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 1.22
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.21
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 1.18
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 1.09
RNA-seq of RKO cells with cTAZ KO or putback 1.09
SOX11 knockdown in B-ALL cell lines 1.09
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 1.09
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.08
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 1.08
mRNA recovered upon RNF219 IP. [RNA-IP] 1.08
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.07
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.07
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.07
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 1.06
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 1.06
Illumina Total RNA-seq in HeLa 1.04
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 1.02
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.99
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.99
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.99
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.98
Gene expression analysis upon mtDNA depletion 0.98
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 0.98
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 0.98
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.97
Metabolism as an early predictor of DPSCs aging 0.95
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.95
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.94
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.94
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 0.9
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.9
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 0.89
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.88
Regulation of hypoxia-inducible factor activity by ZMYND8 0.88
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 0.87
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 0.87
Ribosomal protein RPL26 is the principal target of UFMylation 0.83
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.8
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 0.76
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.73
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.7
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 0.64
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.64
Effect of ILF3 on translation during homeostasis and the antiviral response 0.64
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.61
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.6
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.59
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.59
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.58
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 0.57
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.57
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.55
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.53
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.49
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.49
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.46
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.46
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 0.46
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.46
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.45
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.44
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 0.43
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.42
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.42
RNA-seq differential expression studies: more sequence, or more replication? 0.42
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.41
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.37
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.37
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.37
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 0.34
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 0.32
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.32
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.27
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.26
Silencing SPIB in attached and floating state of H1703 lung cancer cells 0.25
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.23
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.21
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.21
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.19
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.18
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.17
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.15
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.13
Expression analysis of the TAF1 syndrome 0.11
MHC Transcriptomic landscape at haplotype-specific resolution 0.11
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.11
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.1
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 0.09
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.07
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.06
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.01
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.01
Targeting MTHFD2 in Acute Myeloid Leukemia 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation